Biomerica INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

26 Sept 2025

BMRA

10-K/A: Biomerica Amends 10-K, Details Governance & Compensation

Biomerica, Inc. filed an amendment to its 2025 Annual Report, providing updated disclosures on corporate governance, executive compensation, and capital stock structure.

NASDAQ

29 Aug 2025

BMRA

Biomerica INC

10-K: Biomerica Reports FY25 Loss Amid Product Launches, Cost Cuts

Biomerica, a biomedical technology company, reported a net loss of $4.97 million for fiscal year 2025, alongside a 2% decrease in net sales, while actively pursuing commercialization of its inFoods IBS and hp+detect products and implementing significant cost-cutting measures.

NASDAQ

28 Aug 2024

BMRA

Biomerica INC

10-K: Biomerica Reports Fiscal Year 2024 Results Amidst Strategic Shift and Cost-Cutting Measures

Biomerica's fiscal year 2024 saw a revenue increase driven by non-COVID products, alongside cost-cutting measures due to slower-than-expected product launches.